医学
岩下窦
海绵窦
动静脉瘘
外科
闭塞
瘘管
放射外科
栓塞
窦(植物学)
放射科
放射治疗
植物
生物
属
作者
Jong Kook Rhim,Young Dae Cho,Jeong-Jin Park,Jin Pyeong Jeon,Hyun‐Seung Kang,Jeong Eun Kim,Won‐Sang Cho,Moon Hee Han
出处
期刊:Neurosurgery
[Lippincott Williams & Wilkins]
日期:2015-04-03
卷期号:77 (2): 192-199
被引量:52
标识
DOI:10.1227/neu.0000000000000751
摘要
BACKGROUND: Although a transvenous route via the ipsilateral inferior petrosal sinus (IPS) is preferred in treating cavernous sinus dural arteriovenous fistula (CSdAVF), this option may be limited if an occluded ipsilateral IPS undermines microcatheter delivery to the cavernous sinus. OBJECTIVE: To describe our experience with endovascular treatment of CSdAVF complicated by ipsilateral IPS occlusion. METHODS: From January 2003 through September 2014, a total of 49 CSdAVFs with ipsilateral IPS occlusion were identified in 49 patients, who then underwent endovascular treatment. Clinical and radiologic data were retrospectively reviewed. RESULTS: Either transvenous (n = 38) or transarterial (n = 11) access was initially elected, the latter reserved for single-hole or dominant arterial feeder fistulas. Access via occluded ipsilateral IPS was usually attempted (n = 34) by transvenous approach, with a 54.3% success rate. Anterior (n = 3) or posterior (n = 1) facial vein was alternatively used. Direct surgical exposure of ophthalmic vein (n = 3) or radiosurgery (n = 4) was performed for access failure or unsuccessful occlusion by other means. In 46 fistulas (93.9%), complete occlusion was achieved, with no procedure-related morbidity or mortality. Postprocedural symptom improvement was noted in all but 2 patients, who separately experienced paradoxical worsening of cranial nerve palsy and access failure. CONCLUSION: In patients with CSdAVF and ipsilateral IPS occlusion, various treatment strategies may be applied (given angioanatomic suitability), resulting in excellent procedural and short-term follow-up results. Reopening of an occluded IPS is reasonable as an initial access attempt.
科研通智能强力驱动
Strongly Powered by AbleSci AI